Saturday, October 31, 2026

Alibaba And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 14, 2020

Alibaba And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Camtek Ltd.

37.3% sales growth and 13.15% return on equity

Camtek Ltd. sales growth this year is expected to be 12.2% and 9.3% for next year.

Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 140.44M for the twelve trailing months.

Camtek Ltd.'s sales growth for the next quarter is 37.3%. The company's growth estimates for the current quarter and the next is 35.7% and 88.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.15%.

Camtek Ltd.'s Stock Top and Bottom Yearly Value

Camtek Ltd.'s stock is valued at $20.01 at 10:57 EST, under its 52-week high of $21.13 and way above its 52-week low of $6.27.

Camtek Ltd.'s Moving Average

Camtek Ltd.'s worth is higher than its 50-day moving average of $18.93 and way higher than its 200-day moving average of $15.87.

2. Alibaba

66.5% sales growth and 14.58% return on equity

Alibaba sales growth this year is expected to be 47.3% and 31% for next year.

Year-on-year quarterly revenue growth grew by 30.3%, now sitting on N/A for the twelve trailing months.

News about Alibaba today

China fines Alibaba, tencent for flouting rules in past deals. According to today's article on Bloomberg Quint, "China's antitrust watchdog fined Alibaba Group Holding Ltd. ", "While the amount is immaterial to Alibaba, retroactive application of new anti-competitive rules announced in November may be a stern warning to toe the line in future."

Alibaba's sales growth for the next quarter is 66.5%. The company's growth estimates for the present quarter and the next is a negative 81.9% and 55%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.58%.

Alibaba's Stock Top and Bottom Yearly Value

Alibaba's stock is valued at $257.17 at 10:57 EST, way under its 52-week high of $319.32 and way above its 52-week low of $169.95.

Alibaba's Moving Average

Alibaba's worth is under its 50-day moving average of $277.32 and below its 200-day moving average of $263.61.

3. Capital City Bank Group

28.1% sales growth and 12.48% return on equity

Capital City Bank Group sales growth this year is anticipated to be 36.3% and a negative 2.3% for next year.

Year-on-year quarterly revenue growth grew by 49.5%, now sitting on 188.94M for the twelve trailing months.

Capital City Bank Group's sales growth for the next quarter is 28.1%. The company's growth estimates for the current quarter and the next is a negative 2% and 76%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.48%.

Capital City Bank Group's Stock Top and Bottom Yearly Value

Capital City Bank Group's stock is valued at $25.55 at 10:57 EST, way below its 52-week high of $30.95 and way higher than its 52-week low of $15.61.

Capital City Bank Group's Moving Average

Capital City Bank Group's value is way higher than its 50-day moving average of $23.16 and way higher than its 200-day moving average of $20.82.

4. Agnico Eagle Mines Limited

82.6% sales growth and 12.43% return on equity

Agnico Eagle Mines Limited sales growth this year is expected to be 26.7% and 30.7% for next year.

Year-on-year quarterly revenue growth grew by 43.6%, now sitting on 2.96B for the twelve trailing months.

Agnico Eagle Mines Limited's sales growth for the next quarter is 82.6%. The company's growth estimates for the ongoing quarter and the next is 121.6% and 400%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.43%.

Agnico Eagle Mines Limited's Stock Top and Bottom Yearly Value

Agnico Eagle Mines Limited's stock is valued at $70.76 at 10:57 EST, way below its 52-week high of $89.23 and way above its 52-week low of $31.00.

Agnico Eagle Mines Limited's Moving Average

Agnico Eagle Mines Limited's worth is below its 50-day moving average of $73.93 and under its 200-day moving average of $73.29.

5. First Financial Bankshares, Inc.

13.1% sales growth and 13.1% return on equity

First Financial Bankshares, Inc. sales growth this year is expected to be 24.7% and a negative 1.3% for next year.

Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 437.74M for the twelve trailing months.

First Financial Bankshares, Inc.'s sales growth for the next quarter is 13.1%. The company's growth estimates for the current quarter and the next is 23.3% and 42.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.1%.

First Financial Bankshares, Inc.'s Stock Top and Bottom Yearly Value

First Financial Bankshares, Inc.'s stock is valued at $35.32 at 10:57 EST, below its 52-week high of $36.45 and way higher than its 52-week low of $20.70.

First Financial Bankshares, Inc.'s Moving Average

First Financial Bankshares, Inc.'s value is above its 50-day moving average of $33.03 and way above its 200-day moving average of $30.64.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com
Alibaba And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity | Via News